During the past decade, Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika" are "B-cell Malignancies" (1 trials), "Chronic Renal Anemia" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials) and "Lymphoma, Non-Hodgkin" (1 trials). Many other conditions were trialed in "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika" in a lesser frequency.

Most popular intervention types in "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Placebo" (2 trials) and "Darbepoetin Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fakultni nemocnice Kralovske Vinohrady, Interni hematologicka klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".